Accepted at 2:51 p.m. May, 14, 2024 by Ahmed7
Author: skkhoury
Co-authors: DillingerMed
Related Note: 1509290238982
Rationale for change

Way to associate paclitaxel with peripheral neuropathy
Source: Other - .

Extra Extra
Text
{{c2::Paclitaxel}} is a taxane associated with {{c1::peripheral neuropathy::neurotoxicity}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy

Watch Mitotic Inhibitors
Sketchy 2

Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo

Bootcamp
Watch associated Bootcamp video - Mitosis, Meiosis, and the Cell Cycle: Mitosis

Watch associated Bootcamp video - Cell Biology: Cytoskeleton

Watch associated Bootcamp video - Cellular Injury and Neoplasia: Cell Cycle Dependent Drug Targets

Watch associated Bootcamp video - Principles of Oncology and Therapeutics: Cell Cycle Dependent Drug Targets
OME

Additional Resources
One by one
Empty field
#AK_Step1_v12::#B&B::11_Hematology::04_Cancer_Drugs::04_Microtubule_Inhibitors #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::13_Microtubule_Inhibitors !AK_UpdateTags::^temporary::ImageFix::Table #AK_Step1_v12::#Bootcamp::Genetics::04_Mitosis,_Meiosis,_and_the_Cell_Cycle::01_Mitosis !AK_UpdateTags::Step1decks::Lolnotacop::Drugs #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::10_Paclitaxel #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::15_Microtubule_inhibitors::*Taxanes #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::02_DNA_&_Cellular_Division::05_Mitotic_Inhibitors #AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::03_Chronic_Diabetes_Complications_SOAP #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::10_Cell_Cycle_Dependent_Drug_Targets #AK_Step1_v12::#Bootcamp::Biochemistry::01_Cell_Biology::06_Cytoskeleton #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::10_Cell_Cycle_Dependent_Drug_Targets #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::09_Drug_reactions-neurologic #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#OME_banner